Equities

Labcorp Holdings Inc

Labcorp Holdings Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)227.80
  • Today's Change0.785 / 0.35%
  • Shares traded254.08k
  • 1 Year change+13.24%
  • Beta1.0587
Data delayed at least 15 minutes, as of Sep 18 2024 20:03 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Labcorp Holdings Inc. provides comprehensive laboratory services that help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The Company provides insights and advanced science to improve health and improve lives through its unparalleled diagnostics and drug development laboratory capabilities. The Company operates through two segments: Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The Diagnostics Laboratories segment includes routine testing and specialty/esoteric testing. Dx operates through a network of patient service centers, branches, rapid response laboratories, primary laboratories, and specialty laboratories. The Biopharma Laboratory Services segment consists of early development research laboratories and central laboratory services. The Company is also focused on clinical diagnostics and reproductive and women's health in the United States outside of New York and New Jersey.

  • Revenue in USD (TTM)12.49bn
  • Net income in USD449.50m
  • Incorporated2024
  • Employees67.00k
  • Location
    Labcorp Holdings Inc358 S Main StBURLINGTON 27215United StatesUSA
  • Phone+1 (336) 229-1127
  • Fax+1 (302) 636-5454
  • Websitehttps://www.labcorp.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
LH:NYQ since
announced
Transaction
value
Baystate Health Inc-Outreach Laboratory businessAnnounced04 Oct 202304 Oct 2023Announced13.63%--
Data delayed at least 15 minutes, as of Sep 18 2024 20:03 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Solventum Corp8.21bn1.06bn12.49bn22.01k11.804.367.741.526.136.1347.5016.600.58173.977.36372,926.807.50--8.72--56.98--12.89--0.958410.030.7434--0.8241--0.2234------
Davita Inc12.52bn859.62m13.78bn70.00k17.4822.087.281.109.409.40136.767.440.737171.095.81178,919.406.745.629.107.4532.7230.709.158.331.125.260.7876--4.571.2626.442.33-10.47--
Tenet Healthcare Corp20.92bn2.76bn15.04bn78.14k5.744.333.430.719127.3227.32205.2636.270.74149.276.85267,659.7012.523.6118.255.0982.5882.9716.894.951.384.890.62060.007.172.3349.0241.424.01--
Universal Health Services, Inc.15.02bn934.19m15.34bn73.35k17.042.3910.101.0213.6313.63218.7797.211.08--7.05204,737.606.826.448.077.63----6.316.551.176.910.40946.066.595.806.32-1.471.1714.87
Natera Inc1.36bn-292.12m15.73bn3.28k--18.76--11.56-2.47-2.4711.386.780.984115.014.57414,534.80-21.13-36.17-26.88-46.6053.8545.88-21.47-56.154.01--0.3032--31.9933.2620.63--58.81--
Quest Diagnostics Inc9.35bn836.00m17.30bn40.00k20.962.6113.091.857.417.4182.8959.610.684534.237.32233,650.006.369.287.4910.8132.9836.649.2912.970.9128.510.396325.07-6.384.20-9.773.401.277.43
Labcorp Holdings Inc12.49bn449.50m19.06bn67.00k43.152.3818.081.535.265.26146.6195.530.725419.345.82186,382.102.626.273.207.3728.0032.333.619.510.76996.400.391--2.511.42-62.16-16.403.62--
Molina Healthcare Inc37.41bn1.06bn20.69bn18.00k19.324.3016.700.553118.2718.27643.0182.082.59--13.322,078,167.007.377.6215.7816.8015.6815.992.843.04--14.490.32990.006.5612.5237.759.0622.87--
Data as of Sep 18 2024. Currency figures normalised to Labcorp Holdings Inc's reporting currency: US Dollar USD

Institutional shareholders

35.61%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Jun 20249.25m11.01%
BlackRock Fund Advisorsas of 30 Jun 20244.66m5.55%
SSgA Funds Management, Inc.as of 30 Jun 20243.70m4.41%
Wellington Management Co. LLPas of 30 Jun 20242.17m2.59%
BlackRock Advisors LLCas of 30 Jun 20242.02m2.40%
Geode Capital Management LLCas of 30 Jun 20241.95m2.32%
Diamond Hill Capital Management, Inc.as of 30 Jun 20241.95m2.32%
Allspring Global Investments LLCas of 30 Jun 20241.57m1.87%
JPMorgan Investment Management, Inc.as of 30 Jun 20241.32m1.57%
Dimensional Fund Advisors LPas of 30 Jun 20241.31m1.56%
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.